ForPharmacistsImportant Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary Hyperparathyroidism By Julie Reddy / August 26, 2025
ForPharmacists, ForThePublicCOPAXONE (glatiramer acetate) and the Risk of Anaphylactic Reactions Which May Occur at Any Time Following Initiation of Treatment By Julie Reddy / August 22, 2025
